Neuroplastic Change in Myelin of the Brain

Sponsor
University of British Columbia (Other)
Overall Status
Unknown status
CT.gov ID
NCT01937910
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
88
1
2
48
1.8

Study Details

Study Description

Brief Summary

The main goal of this research is to advance understanding of how stroke changes both the structure and function of the brain. The investigators will determine which is the key driver of recovery of arm function after stroke: changes in the structure of the brain or changes in how brain regions interact with one another.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: TRAIT Task
N/A

Detailed Description

The main goal of this research is to advance understanding of how stroke changes both the structure and function of the brain. Further, the investigators will determine which is the key driver of recovery of arm function after stroke: changes in the structure of the brain or changes in how brain regions interact with one another. Together, these data will advance the investigators understanding of how neural systems support recovery from stroke. The investigators will use a MRI technique that allows us to assess the health of a brain structure called myelin. This structure is important as it allows information to travel down nerves faster; the more myelin the quicker the signal can be conducted. The investigators aim is to test whether or not movement training can restore myelin in the brain. If movement training does restore myelin in the brain, the investigators will have identified an important new target for rehabilitation interventions.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
88 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Structural and Functional Correlates of Neuroplastic Change Associated With Stroke
Study Start Date :
Sep 1, 2014
Anticipated Primary Completion Date :
Sep 1, 2017
Anticipated Study Completion Date :
Sep 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stroke Group

Participants in the stroke group will complete 10 training sessions of the TRAIT task.

Behavioral: TRAIT Task
Increased paretic arm will be manipulated through the performance of a semi-immersive virtual reality-based intercept and release task called TRAIT (TRack And Intercept Task), which is performed in an interactive environment. TRAIT employs an open source Kinect sensor, which tracks 3-D joint movement. Participants are asked to control an on-screen icon using movements of their paretic arm to intercept a moving object as it emerges from the side of a computer screen. Once intercepted, they must accurately throw the object to hit a target. Participants move up through 10 levels of the game as their skill improves. Participants will complete 10 TRAIT training sessions in 4 weeks for a total of 10,000 experimental movements.

Active Comparator: Matched Healthy Control Group

Participants in the Matched Healthy Control group will complete 10 sessions of the TRAIT task

Behavioral: TRAIT Task
Increased paretic arm will be manipulated through the performance of a semi-immersive virtual reality-based intercept and release task called TRAIT (TRack And Intercept Task), which is performed in an interactive environment. TRAIT employs an open source Kinect sensor, which tracks 3-D joint movement. Participants are asked to control an on-screen icon using movements of their paretic arm to intercept a moving object as it emerges from the side of a computer screen. Once intercepted, they must accurately throw the object to hit a target. Participants move up through 10 levels of the game as their skill improves. Participants will complete 10 TRAIT training sessions in 4 weeks for a total of 10,000 experimental movements.

Outcome Measures

Primary Outcome Measures

  1. Change in Myelin water fraction [Baseline and 30 days post baseline]

    Myelin water fraction (MWF) is the area of the short T2 component (15-35ms) divided by the total T2 distribution expressed as a percentage (MWF% = MWF*100)

Secondary Outcome Measures

  1. Change in Fractional anisotropy [Baseline and 30 days post baseline]

    Diffusion properties will be defined by calculating a 6-element tensor ellipsoid to provide both the magnitude and direction of diffusivity in a local orthogonal coordinate system within each voxel. Fractional anisotropy (FA) will be calculated to provide an index of microstructural white matter integrity.

Other Outcome Measures

  1. Change in Hemiparetic arm use measured by accelerometry [Baseline and 30 days post baseline]

    Average daily movement counts indexed with accelerometers worn at the wrist

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • individuals aged 40-75

  • movement-related deficits associated with a middle cerebral artery stroke

  • first time stroke affecting the corona radiata and/or internal capsule

  • Fugl-Meyer upper extremity motor score of at least 15 but not greater than 55.

Exclusion Criteria:
  • outside the age range of 40-75

  • show signs of dementia (score < 24 on the Montreal Cognitive Assessment)

  • have aphasia (score < 13 on the Frenchay Aphasia Screen)

  • history of head trauma, a major psychiatric diagnosis, neurodegenerative disorder or substance abuse;

  • taking any drugs (GABAergic, N-methyl-D-aspartate A-receptor (NMDA) antagonist) known to influence neuroplasticity;

  • report contraindications to MRI (see supporting documents)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of British Columbia Vancouver British Columbia Canada V6T 1Z3

Sponsors and Collaborators

  • University of British Columbia
  • Canadian Institutes of Health Research (CIHR)

Investigators

  • Principal Investigator: Lara A Boyd, PT; PhD, University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT01937910
Other Study ID Numbers:
  • H13-01952
First Posted:
Sep 10, 2013
Last Update Posted:
Jan 10, 2017
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by University of British Columbia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2017